{"id":12579,"date":"2016-10-06T16:32:22","date_gmt":"2016-10-06T16:32:22","guid":{"rendered":"https:\/\/www.heartgenetics.com\/vinci\/"},"modified":"2016-10-06T16:32:22","modified_gmt":"2016-10-06T16:32:22","slug":"vinci","status":"publish","type":"page","link":"https:\/\/www.heartgenetics.com\/pt\/sobre-nos\/financed-projects\/vinci\/","title":{"rendered":"Vinci"},"content":{"rendered":"

\"pocentro_pt2020_feder_bom\"<\/a><\/p>\n

 <\/p>\n

Vinci_2<\/h2>\n

HeartGenetics<\/a> project – Vinci_2 – was approved to reinforce its differentiated position on informatics and research. Vinci\u2019s main goal is to reinforce the IT and Genetics team at HeartGenetics<\/a>. Vinci_2 is financed by Portugal 2020, Centro 2020 and the European Regional Development Fund in the eligible amount of 124.090,31\u20ac.<\/p>\n

Goals<\/h2>\n\n
  • Reinforce research, human resources and consolidate HeartGenetics<\/a> I&D team on IT and genetics;<\/li>\n
  • Prepare a new portfolio and new business models;<\/li>\n
  • Prepare the company for an international expansion with new business segments.<\/li>\n<\/menu>\n

     <\/p>\n

    Results<\/h2>\n

    Vinci_2 features the integration of 3 new highly qualified human resources who will play important roles in making sure HeartGenetics<\/a> reaches its strategic goals, notably in pharmacogenetics and wellbeing.<\/p>\n

    \n

    Vinci_2<\/h2>\n

    A HeartGenetics<\/a> recebe a aprova\u00e7\u00e3o do projeto Vinci_2\u00a0 para refor\u00e7ar o seu posicionamento diferenciado em inform\u00e1tica e I&D. O principal objetivo da Vinci \u00e9 refor\u00e7ar a equipe de TI e de gen\u00e9tica da HeartGenetics. Este projeto \u00e9 financiado pelo Portugal 2020, Centro 2020 e Fundo Europeu de Desenvolvimento Regional no valor eleg\u00edvel de 124.090,31 \u20ac.<\/p>\n

    Objetivos<\/h2>\n\n
  • Refor\u00e7ar a investiga\u00e7\u00e3o, os recursos humanos e consolidar a equipa de I&D da HeartGenetics<\/a>.<\/li>\n
  • Preparar um novo portf\u00f3lio e novos modelos de neg\u00f3cios;<\/li>\n
  • Preparar a empresa para a expans\u00e3o internacional e entrada em novos mercados e segmentos.<\/li>\n<\/menu>\n

     <\/p>\n

    Resultados<\/h2>\n

    O projeto VINCI_2 contempla a contrata\u00e7\u00e3o e integra\u00e7\u00e3o de 3 novos recursos humanos altamente qualificados que ir\u00e3o garantir que a HeartGenetics<\/a> atinja seus objetivos estrat\u00e9gicos, principalmente em farmacogen\u00e9tica e bem-estar.<\/p>\n

    \n

    \"pocentro_pt2020_feder_bom\"<\/a><\/p>\n

     <\/p>\n

    Vinci<\/h2>\n

    HeartGenetics<\/a> project – Vinci – was approved to reinforce its differentiated position on cardiovascular genetics. Vinci\u2019s main goal is to reinforce the \u00a0IT and Genetics team at HeartGenetics<\/a>. Vinci is financed by Portugal 2020, Centro 2020 and the European Regional Development Fund in the eligible amount of 102.234,82\u20ac.<\/p>\n

    Goals<\/h2>\n\n
  • Reinforce research, human resources \u00a0and consolidate HeartGenetics<\/a> I&D team;<\/li>\n
  • Promote strategic projects between the industry, hospitals and universities;<\/li>\n
  • Adapt cutting edge technologies in order to consolidate the internationalization process;<\/li>\n
  • Validate HeartGenetics<\/a> on an international level;<\/li>\n<\/menu>\n

     <\/p>\n

    Results<\/h2>\n

    Vinci features the integration of 3 new highly qualified human resources (PhDs and Msc), who will play important roles in making sure HeartGenetics<\/a> reaches its strategic goals. It will also allow the company to gain financial feedback after a heavy investment strategy in I&DT during the last few years.<\/p>\n

    \"PT_flag\"<\/a><\/h4>\n

    \"teamHG\"<\/a><\/p>\n

    \n

     
    \n 
    \n 
    \n 
    \n <\/p>\n

    Vinci<\/h2>\n

    A HeartGenetics<\/a> recebe a aprova\u00e7\u00e3o do projeto Vinci\u00a0 para refor\u00e7ar a sua posi\u00e7\u00e3o diferenciadora na \u00e1rea da gen\u00e9tica cl\u00ednica. Este tem como principal objetivo o refor\u00e7o das suas compet\u00eancias nas \u00e1reas de inform\u00e1tica e da gen\u00e9tica. Este projeto \u00e9 financiado pelo Portugal 2020, Centro2020, no montante eleg\u00edvel de 102.234,82\u20ac, proveniente do fundo europeu de desenvolvimento regional.<\/p>\n

    Objetivos<\/h2>\n\n
  • Refor\u00e7ar as suas compet\u00eancias e recursos humanos da equipa HeartGenetics<\/a><\/li>\n
  • Consolidar a equipa de I&D;<\/li>\n
  • Promover projetos estrat\u00e9gicos entre a ind\u00fastria, os hospitais e as universidades;<\/li>\n
  • Adaptar tecnologias de ponta de modo a consolidar o processo de internacionaliza\u00e7\u00e3o;<\/li>\n
  • Valorizar a HeartGenetics<\/a> a n\u00edvel internacional;<\/li>\n<\/menu>\n

     <\/p>\n

    Resultados<\/h2>\n

    O projeto VINCI contempla a contrata\u00e7\u00e3o e integra\u00e7\u00e3o nos seus quadros fixos de 3 novos recursos humanos altamente qualificados (dois doutorados e um mestre), que ir\u00e3o ter um papel muito relevante para atingir as metas estrat\u00e9gicas definidas pela HeartGenetics<\/a>. Permitir\u00e1 tamb\u00e9m \u00e0 empresa obter retorno financeiro resultante do forte investimento numa estrat\u00e9gia baseada em I&DT efetuado nos \u00faltimos anos.<\/p>\n

    \"PT_flag\"<\/a><\/h4>\n

    \"teamHG\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

      Vinci_2 HeartGenetics project – Vinci_2 – was approved to reinforce its differentiated position on informatics and research. Vinci\u2019s main goal is to reinforce the […]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":12659,"menu_order":53,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-12579","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/pages\/12579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/comments?post=12579"}],"version-history":[{"count":0,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/pages\/12579\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/pages\/12659"}],"wp:attachment":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/media?parent=12579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}